Famprofazone
CAS: 22881-35-2
Ref. 3D-FF23227
| 2mg | Discontinued | ||
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued | ||
| 50mg | Discontinued |
Product Information
- 1,2-Dihydro-1-methyl-4-(1-methylethyl)-5-[[methyl(1-methyl-2-phenylethyl)amino]methyl]-2-phenyl-3H-pyrazol-3-one
- 1-Methyl-5-[[methyl(1-phenylpropan-2-yl)amino]methyl]-2-phenyl-4-propan-2-ylpyrazol-3-one
- 1-methyl-5-{[methyl(1-phenylpropan-2-yl)amino]methyl}-2-phenyl-4-(propan-2-yl)-1,2-dihydro-3H-pyrazol-3-one
- 22881-35-2
- 3-Pyrazolin-5-one, 4-isopropyl-2-methyl-3-[[methyl(α-methylphenethyl)amino]methyl]-1-phenyl-
- 3H-Pyrazol-3-one, 1,2-dihydro-1-methyl-4-(1-methylethyl)-5-[[methyl(1-methyl-2-phenylethyl)amino]methyl]-2-phenyl-
- 4-Isopropyl-1-methyl-5-{[methyl(1-phenylpropan-2-yl)amino]methyl}-2-phenyl-1,2-dihydro-3H-pyrazol-3-one
Famprofazone is a drug that is used to treat inflammatory bowel disease (IBD). It has been shown to have an effect on the activity of effector proteins in inflammatory diseases and cancer. Famprofazone also has a toxicological study and has been shown to be safe for human consumption. The drug binds to receptors in the body, which may explain its effects on autoimmune diseases and bowel disease. This drug can be found in pharmaceutical preparations, such as those used for IBD treatment, as well as wastewater treatment. Famprofazone can also be found in urine samples of humans, where it was detected using analytical methods such as gas chromatography-mass spectrometry. Metabolic profiles are being studied for this drug because it is metabolized by cytochrome P450 enzymes.
